This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...

Abbott Diabetes Care has recalled some of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors for people ...

FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.

"Sensor-based glucose monitoring has transformed diabetes care," said Akshay Jain, M.D., a nationally recognized endocrinologist based in Surrey, British Columbia. "These intuitive tools, like the ...

Coverage means more Canadians with diabetes can access Abbott's sensor-based glucose technology, giving them actionable insights to manage their condition confidently, i "Sensor-based glucose ...

MISSISSAUGA, ON, Jan. 7, 2026 /CNW/ — Abbott’s (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus * sensor, is now publicly funded in every province across Canada vi, in ...

Abbott has now identified the manufacturing issue that caused the fault in the sensors used in its FreeStyle Libre 3 and Libre 3 Plus CGMs. Image credit: Jonathan Weiss via Shutterstock.com. Abbott ...

Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may provide false low glucose readings. Hundreds of adverse events and seven ...

Tandem Diabetes Care (TNDM) begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with ...